Document is current
Any future updates will be listed below
-
Authors
Tremblay, Douglas http://orcid.org/0000-0002-4719-7192
Mesa, Ruben
- License Information
-
More Information
Article History
Accepted: 22 December 2022
First Online: 14 January 2023
Compliance with Ethical Standards
:
: Douglas Tremblay receives contracted research funding paid to his institution from CTI Biopharma, Astellas Pharma, and Gilead and consulting fees from AbbVie, Sierra Oncology, GSK, and Cogent. Ruben Mesa receives contracted research funding paid to his institution from Incyte, Sierra, CTI BioPharma, Bristol Myers Squibb, AbbVie, Genentech, Blueprint, and Morphosys and consulting fees from Novartis, Sierra Oncology, Genentech, Sierra, Blueprint, Geron, Telios, CTI BioPharma, Incyte, Bristol Myers Squibb, AbbVie, and GSK.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
